Table 2.

Overall and progression-free survival according to serum uPA levels and circulating tumor cell counts.

	Median PFS Months [95%-CI]		Median OS Months [95%-CI]
	≥5 CTCs	<5 CTCs	≥5 CTCs	<5 CTCs
uPA ≥2.52 ng/ml	5.3 [1.7–8.9]	4.2 [1.2–7.2]	7.2 [5.1–9.3]	Not reached (mean 14.1)
uPA < 2.52 ng/ml	5.7 [3.8–7.6]	10.8 [9.1–12.5]	17.8 [10.8–24.8]	Not reached (mean 20.8)